These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30474104)

  • 1. Bone-Targeted Therapy in Early Breast Cancer.
    Jerzak KJ; Raphael J; Desautels DN; Blanchette PS; Tyono I; Pritchard KI
    Oncology (Williston Park); 2018 Nov; 32(11):562-9. PubMed ID: 30474104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of glucocorticoid-induced osteoporosis: What is new?
    Compston J
    Int J Rheum Dis; 2019 Sep; 22(9):1595-1597. PubMed ID: 31478605
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer and osteoporosis.
    Cheung AM; Heisey R; Srighanthan J
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):532-8. PubMed ID: 24468755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of individual risk for osteoporotic fracture.
    Wood WA; Muss H
    Oncology (Williston Park); 2010 Jul; 24(8):753-5. PubMed ID: 20718256
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.
    Rizzoli R; Body JJ; DeCensi A; Reginster JY; Piscitelli P; Brandi ML;
    Osteoporos Int; 2012 Nov; 23(11):2567-76. PubMed ID: 22270857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer].
    Eiken PA; Hansen M; Kristensen B; Langdahl BL; Abrahamsen B
    Ugeskr Laeger; 2011 Feb; 173(8):577-81. PubMed ID: 21333258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis, fractures, and risk of falls.
    Cohen MJ; Naeim A
    Oncology (Williston Park); 2010 Jul; 24(8):752-3. PubMed ID: 20718255
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone complications of cancer treatment in the elderly.
    Balducci L
    Oncology (Williston Park); 2010 Jul; 24(8):741-7. PubMed ID: 20718254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women and bone health: maximizing the benefits of aromatase inhibitor therapy.
    Tang SC
    Oncology; 2010; 79(1-2):13-26. PubMed ID: 21051913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone health after diagnosis of breast cancer.
    Ruzycki SM; Nixon NA
    CMAJ; 2018 Dec; 190(49):E1452. PubMed ID: 30530612
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.
    Strobl S; Wimmer K; Exner R; Devyatko Y; Bolliger M; Fitzal F; Gnant M
    Curr Treat Options Oncol; 2018 Mar; 19(4):18. PubMed ID: 29527635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors.
    Martínez P; Galve E; Arrazubi V; Sala MÁ; Fernández S; Pérez CE; Arango JF; Torre I
    Reumatol Clin (Engl Ed); 2019; 15(4):211-217. PubMed ID: 29032291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):203-210. PubMed ID: 29232356
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment effect of breast cancer and prostate cancer on bone].
    Varsavsky M; Guadalix Iglesias S
    Med Clin (Barc); 2013 Feb; 140(4):164-8. PubMed ID: 22841464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.
    Body JJ; Bergmann P; Boonen S; Boutsen Y; Devogelaer JP; Goemaere S; Reginster JY; Rozenberg S; Kaufman JM
    Osteoporos Int; 2007 Nov; 18(11):1439-50. PubMed ID: 17690930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.
    Gibson K; O'Bryant CL
    J Oncol Pharm Pract; 2008 Sep; 14(3):139-45. PubMed ID: 18719068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison table: Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):e210-e212. PubMed ID: 29232357
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs for the treatment of metabolic bone diseases.
    Drake MT; Cremers S; Russell RG; Bilezikian JP
    Br J Clin Pharmacol; 2019 Jun; 85(6):1049-1051. PubMed ID: 30950086
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy.
    Diana A; Carlino F; Giunta EF; Franzese E; Guerrera LP; Di Lauro V; Ciardiello F; Daniele B; Orditura M
    Curr Treat Options Oncol; 2021 Apr; 22(5):45. PubMed ID: 33864145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.